These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 33097001

  • 1. Cardiovascular outcomes following percutaneous coronary intervention with drug-eluting balloons in chronic kidney disease: a retrospective analysis.
    Jonas M, Kagan M, Sella G, Haberman D, Chernin G.
    BMC Nephrol; 2020 Oct 23; 21(1):445. PubMed ID: 33097001
    [Abstract] [Full Text] [Related]

  • 2. Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODIGY trial.
    Crimi G, Leonardi S, Costa F, Adamo M, Ariotti S, Valgimigli M.
    Int J Cardiol; 2016 Jun 01; 212():110-7. PubMed ID: 27038714
    [Abstract] [Full Text] [Related]

  • 3. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
    Grandjean-Thomsen NL, Marley P, Shadbolt B, Farshid A.
    Nephron; 2017 Jun 01; 137(1):23-28. PubMed ID: 28478459
    [Abstract] [Full Text] [Related]

  • 4. Everolimus Eluting Stents in Patients with Diabetes Mellitus and Chronic Kidney Disease: Insights from the TUXEDO Trial.
    Bangalore S, Abhaichand R, Mullasari A, Jain R, Chand RKP, Arambam P, Kaul U.
    Cardiovasc Revasc Med; 2019 Dec 01; 20(12):1075-1080. PubMed ID: 31036397
    [Abstract] [Full Text] [Related]

  • 5. Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease.
    Siddiqi OK, Smoot KJ, Dufour AB, Cho K, Young M, Gagnon DR, Ly S, Temiyasathit S, Faxon DP, Gaziano JM, Kinlay S.
    Heart; 2015 Oct 01; 101(19):1569-76. PubMed ID: 26209334
    [Abstract] [Full Text] [Related]

  • 6. Short and long term outcome of percutaneous coronary intervention with drug eluting stent and bare metal stent in patients with chronic kidney disease.
    Resmini C, Di Cuia M, Ballocca F, D'Ascenzo F, Bollati M, Moretti C, Omedè PL, Sciuto F, Gaita F, Sheiban I.
    Minerva Cardioangiol; 2012 Dec 01; 60(6):573-80. PubMed ID: 23147435
    [Abstract] [Full Text] [Related]

  • 7. Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials.
    Baber U, Giustino G, Sartori S, Aquino M, Stefanini GG, Steg PG, Windecker S, Leon MB, Wijns W, Serruys PW, Valgimigli M, Stone GW, Dangas GD, Morice MC, Camenzind E, Weisz G, Smits PC, Kandzari D, Von Birgelen C, Mastoris I, Galatius S, Jeger RV, Kimura T, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Kastrati A, Chieffo A, Mehran R.
    JACC Cardiovasc Interv; 2016 Jan 11; 9(1):28-38. PubMed ID: 26762908
    [Abstract] [Full Text] [Related]

  • 8. Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents.
    Kersting S, Grumann T, Hummel J, Hauschke D, Bode C, Hehrlein C.
    Crit Pathw Cardiol; 2012 Sep 11; 11(3):152-9. PubMed ID: 22825536
    [Abstract] [Full Text] [Related]

  • 9. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
    Dan K, Miyoshi T, Nakahama M, Mizuno T, Kagawa K, Naito Y, Kawada S, Ito H.
    Cardiorenal Med; 2018 Sep 11; 8(2):151-159. PubMed ID: 29617004
    [Abstract] [Full Text] [Related]

  • 10. One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease.
    Mankerious N, Toelg R, Vogel B, Sartori S, Angiolillo DJ, Vranckx P, Feng Y, de la Torre Hernandez JM, Krucoff MW, Bhatt DL, Spirito A, Cao D, Chehab BM, Kunadian V, Maksoud A, Picon H, Sardella G, Thiele H, Varenne O, Windecker S, Richardt G, Valgimigli M, Mehran R.
    Am J Cardiol; 2024 Aug 15; 225():25-34. PubMed ID: 38871156
    [Abstract] [Full Text] [Related]

  • 11. Impact of chronic kidney disease on long-term clinical outcomes of everolimus-eluting stent implantation: A subanalysis of the Tokyo-MD PCI registry.
    Miyazaki T, Ashikaga T, Asano M, Sasaoka T, Kurihara K, Yoshikawa S, Isobe M, Tokyo-MD PCI Study Investigators.
    Catheter Cardiovasc Interv; 2019 Jul 01; 94(1):E9-E16. PubMed ID: 30714680
    [Abstract] [Full Text] [Related]

  • 12. Percutaneous Coronary Intervention Does Not Lower Cardiovascular Outcomes in Patients with Chronic Kidney Disease.
    Chernin G, Chen S, Ozan O, Liu M, Haberman D, Perlman G, Ben-Yehuda O, Jonas M.
    Am J Nephrol; 2019 Jul 01; 50(6):465-472. PubMed ID: 31655801
    [Abstract] [Full Text] [Related]

  • 13. One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry.
    Scholz SS, Lauder L, Ewen S, Kulenthiran S, Marx N, Sakhov O, Kauer F, Witkowski A, Vaglimigli M, Wijns W, Scheller B, Böhm M, Mahfoud F.
    Clin Res Cardiol; 2020 Jul 01; 109(7):845-856. PubMed ID: 31792571
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).
    Dasari TW, Cohen DJ, Kleiman NS, Keyes MJ, Yen CH, Hanna EB, Saucedo JF.
    Am J Cardiol; 2014 Feb 15; 113(4):621-5. PubMed ID: 24342762
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.
    Roberts JK, Rao SV, Shaw LK, Gallup DS, Marroquin OC, Patel UD.
    Am J Cardiol; 2017 May 01; 119(9):1344-1351. PubMed ID: 28318510
    [Abstract] [Full Text] [Related]

  • 19. Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease.
    Kao CC, Wu MS, Chuang MT, Lin YC, Huang CY, Chang WC, Chen CW, Chang TH.
    PLoS One; 2021 May 01; 16(8):e0255645. PubMed ID: 34347826
    [Abstract] [Full Text] [Related]

  • 20. Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry.
    Lee JM, Kang J, Lee E, Hwang D, Rhee TM, Park J, Kim HL, Lee SE, Han JK, Yang HM, Park KW, Na SH, Kang HJ, Koo BK, Kim HS.
    JACC Cardiovasc Interv; 2016 Oct 24; 9(20):2097-2109. PubMed ID: 27692820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.